The Enterprise Value as of October 2024 (TTM) for Satsuma Pharmaceuticals, Inc. (STSA) is 17.06M

According to Satsuma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.06M. This represents a change of -75.20% compared to the average of 68.77M of the last 4 quarters.

Satsuma Pharmaceuticals, Inc. (STSA) Historical Enterprise Value (quarterly & annually)

How has STSA Enterprise Value performed in the past?

The mean historical Enterprise Value of Satsuma Pharmaceuticals, Inc. over the last ten years is 75.56M. The current 17.06M Enterprise Value has changed 2.16% with respect to the historical average. Over the past ten years (40 quarters), STSA's Enterprise Value was at its highest in in the June 2020 quarter at 472.12M. The Enterprise Value was at its lowest in in the September 2019 quarter at -17687854.96.

Satsuma Pharmaceuticals, Inc. (STSA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Satsuma Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Satsuma Pharmaceuticals, Inc. (STSA) Average Enterprise Value

How has STSA Enterprise Value performed in the past?

The current Enterprise Value of Satsuma Pharmaceuticals, Inc. (STSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Satsuma Pharmaceuticals, Inc. (STSA) Enterprise Value vs. Peers

How is STSA’s Enterprise Value compared to its peers?

Satsuma Pharmaceuticals, Inc.’s Enterprise Value is less than ZIVO Bioscience, Inc. (68.78M), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Erasca, Inc. (672.18M), greater than Forte Biosciences, Inc. (-3005280.00), greater than Applied Molecular Transport Inc. (-5743713.00), greater than SAB Biotherapeutics, Inc. (13.57M), less than Senti Biosciences, Inc. (29.73M), greater than Cingulate Inc. (13.62M), greater than Bellicum Pharmaceuticals, Inc. (-5130674.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kronos Bio, Inc. (13.00M), greater than Cyclerion Therapeutics, Inc. (1.92M), less than Larimar Therapeutics, Inc. (474.17M), greater than Addex Therapeutics Ltd (10.17M), greater than Achilles Therapeutics plc (-49970978.00), less than Assembly Biosciences, Inc. (97.39M), less than CytomX Therapeutics, Inc. (59.12M), less than Instil Bio, Inc. (335.48M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than PMV Pharmaceuticals, Inc. (46.07M), less than Eliem Therapeutics, Inc. (119.64M), less than MediciNova, Inc. (44.68M), less than Pharvaris N.V. (714.85M), less than PepGen Inc. (242.40M),

Build a custom stock screener for Satsuma Pharmaceuticals, Inc. (STSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Satsuma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Satsuma Pharmaceuticals, Inc. (STSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Satsuma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.